{"organizations": [], "uuid": "120d0aeffc886f0204509de5623abd90a3314867", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 3402, "shares": 3402, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "https://images.wsj.net/im-7556/social", "site_section": "https://www.wsj.com/europe", "section_title": "The Wall Street Journal &amp; Breaking News, Business, Financial and Economic News, World News and Video", "url": "https://www.wsj.com/articles/fda-panel-backs-proposed-epilepsy-drug-derived-from-cannabis-1524156834", "country": "US", "domain_rank": 387, "title": "FDA Panel Backs Proposed Epilepsy Drug Derived From Cannabis", "performance_score": 10, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.576, "site_type": "news", "published": "2018-04-19T20:53:00.000+03:00", "replies_count": 0, "uuid": "120d0aeffc886f0204509de5623abd90a3314867"}, "author": "Peter Loftus", "url": "https://www.wsj.com/articles/fda-panel-backs-proposed-epilepsy-drug-derived-from-cannabis-1524156834", "ord_in_thread": 0, "title": "FDA Panel Backs Proposed Epilepsy Drug Derived From Cannabis", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "food and drug administration", "sentiment": "negative"}, {"name": "fda panel backs", "sentiment": "negative"}, {"name": "gw pharmaceuticals plc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "An advisory panel to the Food and Drug Administration recommended the agency approve what could become the first prescription drug in the U.S. derived from the marijuana plant, as a treatment for people with rare forms of epilepsy.\n\nA committee on Thursday voted 13-0 that the risk-benefit profile was favorable for GW Pharmaceuticals PLCâ€™s drug, cannabidiol, to treat seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in patients 2 years of age and older. The rare disorders involve frequent or difficult-to-treat...  ", "external_links": [], "published": "2018-04-19T20:53:00.000+03:00", "crawled": "2018-04-20T01:44:12.003+03:00", "highlightTitle": ""}